Content Validity, Acceptability, and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary and the Electronic Hidradenitis Suppurativa Symptom Questionnaire

被引:0
|
作者
Ingram, J. R. [1 ]
Ciaravino, V [2 ]
Rolleri, R. [3 ]
Gillard, P. [4 ]
Pansar, I [4 ]
Taylor, N. [5 ]
Kirby, J. S. [6 ]
机构
[1] Cardiff Univ, Cardiff, Wales
[2] UCB Pharma, Colombes, France
[3] UCB Pharma, Morrisville, NC USA
[4] UCB Pharma, Brussels, Belgium
[5] Evidera, Bethesda, MD USA
[6] Penn State Univ, Hershey, PA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR36
引用
收藏
页码:S396 / S397
页数:2
相关论文
共 50 条
  • [1] Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire and Hidradenitis Suppurativa Quality of Life Questionnaire
    Ingram, John R.
    Ciaravino, Valerie
    Rolleri, Robert
    Pansar, Ingrid
    Dias-Barbosa, Carla
    Kirby, Joslyn
    DERMATOLOGY, 2024, 240 (01) : 65 - 76
  • [2] ACCEPTABILITY AND USABILITY OF THE ELECTRONIC HIDRADENITIS SUPPURATIVA QUALITY OF LIFE QUESTIONNAIRE
    Kirby, J. S.
    Ciaravino, V.
    Rolleri, R.
    Gillard, P.
    Pansar, I
    Taylor, N.
    Ingram, J. R.
    VALUE IN HEALTH, 2022, 25 (12) : S433 - S433
  • [3] Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom Diary
    Alavi, Afsaneh
    Baradaran, Sarah
    Mathias, Susan D.
    Colwell, Hilary H.
    Song, Michael
    Hamzavi, Iltefat H.
    Han, Chenglong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1123 - 1125
  • [4] PSYCHOMETRIC VALIDATION OF THE ELECTRONIC HIDRADENITIS SUPPURATIVA (HS) SYMPTOM DAILY DIARY (EHSSDD) AND ELECTRONIC HS SYMPTOM QUESTIONNAIRE (EHSSQ) USING DATA FROM THE PHASE 3 BE HEARD TRIALS OF BIMEKIZUMAB IN HS
    Ingram, J. R.
    Kirby, J.
    Ciaravino, V
    Rolleri, R.
    Pansar, I
    Lambert, J.
    Muller, E.
    Pelligra, C.
    VALUE IN HEALTH, 2023, 26 (06) : S280 - S280
  • [5] The validity of the diagnostic code for hidradenitis suppurativa in an electronic database
    Kim, G. E.
    Shlyankevich, J.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (02) : 338 - 342
  • [6] Hidradenitis Suppurativa Symptom Relief Pain and Itch
    Pulminskas, Anna
    Hojjatie, Roxana
    Karatas, Turkan Banu
    Li, Yiwen H.
    Orenstein, Lauren A. V.
    DERMATOLOGIC CLINICS, 2025, 43 (02) : 247 - 260
  • [7] Score interpretation of the Hidradenitis Suppurativa Symptom Assessment (HSSA) and Hidradenitis Suppurativa Impact Assessment (HSIA)
    Kimball, Alexandra B.
    Calimlim, Brian
    Chen, Naijun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB121 - AB121
  • [8] Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient Tool for hidradenitis suppurativa specialty clinics
    Wendland, Zachary
    Rypka, Katelyn J.
    Greenlund, Lindsey
    Herzog, Claire
    Khalid, Bisma
    Steinhaus, Jennifer
    Goldfarb, Noah
    JAAD INTERNATIONAL, 2025, 19 : 83 - 85
  • [9] Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data
    Ingram, John R.
    Lambert, Jeremy
    Ciaravino, Valerie
    Rolleri, Robert
    Pansar, Ingrid
    Peterson, Luke
    Pelligra, Christopher G.
    Thorlacius, Linnea
    DERMATOLOGY AND THERAPY, 2025, : 1093 - 1111
  • [10] Lifestyle modifications associated with symptom improvement in Hidradenitis Suppurativa patients
    Macklis, P.
    Tyler, K.
    Kaffenberger, J.
    Kwatra, S. G.
    Kaffenberger, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S54 - S54